Publications
325
Citations
10,854
Est. group size
—
Recurring co-author estimate
Active years
34
Publishing since 1993
Typically publishes in teams of ~9 · 20% small-team papers (≤3 authors) · across 35 venues
- Etranacogene dezaparvovec in people with hemophilia B with preexisting adeno-associated virus 5 neutralizing antibodies: 4-year subgroup results from the HOPE-B trial
Research and Practice in Thrombosis and Haemostasis · 2026
- Durability of efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A: final phase 3 GENEr8-1 trial results
Research and Practice in Thrombosis and Haemostasis · 2026
- Durability of efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A: final phase 3 GENEr8-1 trial results
UNC Libraries · 2026
- Haemophilia
The Lancet · 2025
- Safety and efficacy of a fitusiran antithrombin-based dose regimen in people with hemophilia A or B: the ATLAS-OLE study
Blood · 2025
- Completion of phase 2b trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B over 5 years
Blood Advances · 2025
- Accurate evaluation of factor VIII activity of efanesoctocog alfa in the presence of emicizumab
Journal of Thrombosis and Haemostasis · 2025
- Final Analysis of a Study of Etranacogene Dezaparvovec for Hemophilia B
New England Journal of Medicine · 2025
- Corticosteroid use to mitigate transaminitis-associated decline in FVIII levels following valoctocogene roxaparvovec gene therapy: clinical practice guidance
Journal of Thrombosis and Haemostasis · 2025
- Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice
Research and Practice in Thrombosis and Haemostasis · 2025
- Global Comparative Antithrombin Field Study: Impact of Laboratory Assay Variability on the Assessment of Antithrombin Activity Measurement at Fitusiran Clinical Decision‐Making Points
Haemophilia · 2025
- Gene-based therapies for hemophilia
Research and Practice in Thrombosis and Haemostasis · 2025
- Gene therapy for hemophilia B: results from the phase 1/2 101HEMB01/02 studies
Blood Advances · 2025
- Development of a novel gene editing lexicon for hemophilia: methodology and results
Research and Practice in Thrombosis and Haemostasis · 2025
- Operationalising a Haemophilia Gene Editing Lexicon for Practical Use
Haemophilia · 2025
- Blood×53
- Haemophilia×35
- Research and Practice in Thrombosis and Haemostasis×26
- Journal of Thrombosis and Haemostasis×15
- Hämostaseologie×9
- Amy L. Dunn
Medicine · The Ohio State University
- S. W. PIPE
Medicine · University of Michigan
- Jessica H. Lewis
Medicine · The Ohio State University
- Radosław Kaczmarek
Medicine · Indiana University
- D. R. Siemieniak
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile